An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes

Sandrine Levet(Biology of Infection), Hervé Perron(Université Claude Bernard Lyon 1)

JCI Insight

September 6, 2017

10.1172/jci.insight.94387

Cited by 84

Related Papers

HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms

|Frontiers in Immunology|2022|41

Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease

|Preprints.org|2021|12

SARS-CoV-2 induces human endogenous retrovirus type W envelope protein expression in blood lymphocytes and in tissues of COVID-19 patients

|medRxiv|2022|7

Blood parameters differentiate post COVID-19 condition from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia

|Brain Behavior & Immunity - Health|2025|5

SARS-CoV-2 induces transcription of human endogenous retrovirus RNA followed by type W envelope protein expression in human lymphoid cells.

|Research Square|2021|4